Thursday, September 8 from 4:30 to 6:30 p.m. at Cherokee Town & Country Club
With nearly one billion people impacted by neurological disorders, the Atlanta Neuroscience Foundation (ANF) will help fund the treatment of Alzheimer’s, Parkinson’s, Multiple Sclerosis and Epilepsy at one of the nation’s largest neurological practices. The organization intends to close the gap between the unacceptably high number of patients who cannot obtain quality, affordable healthcare.
“We want to ensure that all patients with chronic neurological illnesses have access to the complex health care services they and their family need,” said Dr. Jeffrey English, medical director of the Atlanta Neuroscience Institute. “Through our foundation, we hope to enable the best possible access and remove all barriers to care.”
Formed as the philanthropic arm of the Atlanta Neuroscience Institute, formerly the Multiple Sclerosis Center of Atlanta, the ANF will provide financial aid to pay for cutting-edge medicine and comprehensive treatment as well as education and access for both the patient and the family that cares for them.
It is estimated that the United States pays over $50 billion a year in healthcare costs associated with falls in patients over the age of 65. Treatment of neurological disorders ranks among the 10 highest costs. Deaths and disability caused by neurological disorders are fast becoming a global public health challenge, and the burden is set to escalate as our population ages.
The foundation is committed to improving the lives of those impacted by neurological diseases by funding holistic wellness medical programs like PD360, designed to preserve independence through gait training, nutrition, exercise, social and medical services. A program of this kind has been clinically proven to greatly benefit patients however healthcare insurance doesn’t always cover this valuable, life-changing experience.
The Atlanta Neuroscience Institute has grown and evolved since it began as the Atlanta Neurological Clinic in the 1970s. Then, neurology was so specialized that it was one of only two private practices in Metro Atlanta. It was the first practice in the Southeast (one of first three in the country after the Mayo Clinic and Dent Institute) to use CT scans to diagnose neurological diseases. And by the mid-1980s, it was the first to use MRIs as a diagnostic to determine the severity of the illness and therefore develop a plan of care.
Today, the Institute is one of the largest in the nation, matching all four disciplines — Alzheimer’s, Parkinson’s, Multiple Sclerosis and Epilepsy – with leading neurological specialists. It draws from 34 states and sees more than 7,000 patient visits per year. By expanding the scope of care, the Institute can provide the best possible from leading practitioners, and the ANF will help fund it.
About Atlanta Neuroscience Foundation
The Atlanta Neuroscience Foundation, launched in 2022, is the nonprofit and fundraising arm of the Atlanta Neuroscience Institute (fka MS Center of Atlanta).
ANF’s strategic vision includes high quality healthcare and programming excellence in the field of neuroscience, with specialties in Multiple Sclerosis, Epilepsy, Parkinson’s and Movement Disorders, and Alzheimer’s. The doctors and staff affiliated with Atlanta Neuroscience Institute help patients receive life-changing neurological care through financial assistance, cutting edge medicine, and comprehensive treatment.
The funds raised and advocacy led by ANF will help achieve breakthroughs in access to healthcare through affordability, innovations in research, and empower people affected by neurological diseases to live their best lives. The ANF leadership stands in a core founding principle that patients are at the center of their healthcare decision-making. More at www.atlantaneurosciencefoundation.org.
